Skip to product information
1 of 1

AICDA Recombinant Rabbit mAb (S-1030-15)

AICDA Recombinant Rabbit mAb (S-1030-15)

Catalog Number: S0B0702 Application: WB,IHC-P,IP Reactivity: Human Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Synonyms Single-stranded DNA cytosine deaminase, Activation-induced cytidine deaminase (AID), Cytidine aminohydrolase, AID
Immunogen Synthetic Peptide
Location Cytoplasm, Nucleus
Accession Q9GZX7
Clone Number S-1030-15
Antibody Type Recombinant mAb
Isotype IgG
Application WB, IHC-P, IP
Reactivity Hu
Predicted Reactivity Bv, Dg
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000
IP 1:50
IHC-P 1:100

Background

The AICDA protein, also known as Activation-Induced Cytidine Deaminase (AID), plays a crucial role in the immune system. As an enzyme, it mediates affinity maturation and promotes DNA demethylation in germinal center B cells. Specifically, AICDA is essential for generating antibody diversity and forming immune memory by inducing mutations and recombination in antibody genes. It facilitates somatic hypermutation and class switch recombination in immunoglobulin genes, thus enhancing the diversity and specificity of antibodies. However, abnormal expression of AICDA has also been associated with certain diseases. For instance, overexpression of AICDA has been shown to render BCL2-driven mouse lymphomas more aggressive. Additionally, excessive expression of AICDA is considered an important source of epigenetic heterogeneity in diffuse large B-cell lymphoma (DLBCL), which is primarily associated with relative loss of cytosine methylation, increasing tumor heterogeneity and overall adaptive capacity.

Picture

Western Blot

WB result of AICDA Rabbit mAb
Primary antibody: AICDA Rabbit mAb at 1/1000 dilution
Lane 1: K562 whole cell lysate 20 µg
Lane 2: Daudi whole cell lysate 20 µg
Lane 3: Ramos whole cell lysate 20 µg
Lane 4: Raji whole cell lysate 20 µg
Negative control: K562 whole cell lysate
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 24 kDa
Observed MW: 24 kDa

IP

AICDA Rabbit mAb at 1/50 dilution (1 µg) immunoprecipitating AICDA in 0.4 mg Daudi whole cell lysate.
Western blot was performed on the immunoprecipitate using AICDA Rabbit mAb at 1/1000 dilution.
Secondary antibody (HRP) for IP was used at 1/1000 dilution.
Lane 1: Daudi whole cell lysate 20 µg (Input)
Lane 2: AICDA Rabbit mAb IP in Daudi whole cell lysate
Lane 3: Rabbit monoclonal IgG IP in Daudi whole cell lysate
Predicted MW: 24 kDa
Observed MW: 24 kDa

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human tonsil. Anti-AICDA antibody was used at 1/100 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)